about
Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancerSchisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver DiseaseDocosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.Fibrosis, gene expression and orbital inflammatory disease.Adiponectin regulates aquaglyceroporin expression in hepatic stellate cells altering their functional state.Adipose tissue: between the extremes.Serum adipokines levels in patients with systemic sclerosis: A meta-analysis.Hepatic stellate cells as key target in liver fibrosis.Astragaloside IV synergizes with ferulic acid to suppress hepatic stellate cells activation in vitro.Body-mass index is associated with fibrosis regression during long-term nucleoside analogue therapy in chronic hepatitis B.Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity.SIRT1/HSF1/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress.Novel Insights into How Overnutrition Disrupts the Hypothalamic Actions of Leptin.Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice.Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease.
P2860
Q26764921-8624DA94-2C4F-463C-A228-E80769B942AFQ28078342-A043B4CE-F067-4F4E-92E0-20CFB9518553Q33579420-9B826015-604C-49D6-BA14-FAFCFCF75AD0Q36093199-DC6248B4-8756-475E-9619-7C282C8FE8E8Q36588292-71ED99EF-7EBB-4E6B-94E5-9D8D646A40F1Q37018290-4ECD6766-BB9A-4322-A31E-B1AC6A3523C0Q38777796-12385870-C56C-4BC9-B9EE-A8B18A4CC75EQ39379288-DC33DD0D-2503-4176-87D8-D8021D5634B5Q39671627-460E738A-54D9-4C08-882E-1B3379E333CCQ40200602-6097263E-71A6-429C-A86E-A3849288E313Q46424713-B94F3E7B-D6CF-4B70-95E6-A16EC8CFC2D6Q48339011-54D2D855-C18F-49C9-8CA0-C0F6B9CC4F80Q49144853-C8BC82C5-9E09-4025-BB23-BF300F5F301EQ51036933-1A4D53BC-68A5-4711-966B-A15613E94C36Q52597655-321C3575-724B-4D99-A4BF-C32EDA469DB6Q53799057-AFA53E70-7D70-490C-A02A-A31C27447FA3Q55379918-96C6C1E1-7B2E-4A36-AE9E-654B454635CD
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Adipocytokines and hepatic fibrosis.
@en
type
label
Adipocytokines and hepatic fibrosis.
@en
prefLabel
Adipocytokines and hepatic fibrosis.
@en
P2860
P921
P1476
Adipocytokines and hepatic fibrosis.
@en
P2093
Frank A Anania
Neeraj K Saxena
P2860
P304
P356
10.1016/J.TEM.2015.01.002
P5008
P577
2015-02-02T00:00:00Z
2015-03-01T00:00:00Z